AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15733875
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol 50 mug orally every 4 h
Trial: 15733875
Drug: Intracervical dinoprostone
RxNorm normalized name: Dinoprostone
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intracervical dinoprostone 0.5 mg every 6 h
Trial: 12938066
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg of amitriptyline
Trial: 12938066
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of mirtazapine
Trial: 31570179
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg L-DOPA
Trial: 18450126
Drug: Echinacea (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Echinacea (3 capsules twice daily for 8 weeks)
Trial: 18450126
Drug: Placebo (parsley,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (parsley, 3 capsules twice daily for 8 weeks)
Trial: 16621618
Drug: Intravenous methyl
RxNorm normalized name: methylal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous methyl prednisolone for 5 days along with antiepileptic drug
Trial: 16621618
Drug: Antiepileptic drug
RxNorm normalized name: ANTIEPILEPTICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiepileptic drug monotherapy
Trial: 14615654
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa 40,000 to 60,000 U once weekly (QW)
Trial: 14615654
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa 100 to 300 U/kg three times weekly (TIW)
Trial: 9157582
Drug: Combined prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined prescription and monitoring charts for heparin
Trial: 9157582
Drug: Combined prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined prescription and monitoring charts for warfarin
Trial: 1286541
Drug: Long acting
RxNorm normalized name: Long Acting Nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long acting crystalline zinc insulin
Trial: 23940000
Drug: Topical atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical atorvastatin 1% ointment applied once/day for 14 days
Trial: 20038732
Drug: Four courses
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four courses of chemotherapy
Trial: 20038732
Drug: Five courses
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five courses of chemotherapy
Trial: 14638354
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa (40,000 units, s.c. once weekly)
Trial: 14638354
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care (SOC) for anemia management (RBV dose reduction or discontinuation, transfusions)
Trial: 10972451
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment (CBT) for panic disorder, 12 hours in addition to regular alcoholism treatment program.
Trial: 10972451
Drug: Regular alcoholism
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular alcoholism treatment program (Control group).
Trial: 1738796
Drug: Physostigmine (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine (0.75 mg SC)
Trial: 1738796
Drug: Hyoscine (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine (1.2 mg)
Trial: 2121574
Drug: Flecainide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flecainide (200 mg)
Trial: 29402358
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard treatment without early mobilization)
Trial: 24701731
Drug: Fresh gas
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh gas flow (FGF) rate at 0.5 L x min(‐1)
Trial: 24701731
Drug: Fresh gas
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh gas flow (FGF) rate at 1 L x min(‐1)
Trial: 24701731
Drug: Fresh gas
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh gas flow (FGF) rate at 2 L x min(‐1)
Trial: 16878408
Drug: Chemo-radiation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemo-radiation therapy
Trial: 3926729
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion added to parenteral feed
Trial: 3926729
Drug: Without insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Without insulin
Trial: 30640244
Drug: Local infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local infiltration analgesia (LIA) with bupivacaine and levobupivacaine 2 mg/kg and adrenaline 0.5 mg
Trial: 26011733
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose praziquantel (40 mg/kg body weight)
Trial: 26011733
Drug: Double dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double dose praziquantel (40 mg/kg body weight, second dose 2 weeks later)
Trial: 19029226
Drug: r-metHuLeptin treatment
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r-metHuLeptin treatment
Trial: 15326246
Drug: Albuterol (sustained-release,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (sustained-release, 8 mg BID)
Trial: 9401646
Drug: Exogenous GLP-1
RxNorm normalized name: Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exogenous GLP-1 [7-36 amide] infusion (0.4, 0.8 pmol kg-1 min-1)
Trial: 9401646
Drug: Liquid mixed
RxNorm normalized name: ENSURE CLEAR LIQUID MIXED BERRY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid mixed meal (50 g sucrose in 400 ml 8% amino acid)
Trial: 9401646
Drug: Placebo (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (control for GLP-1 infusion)
Trial: 8221563
Drug: GM-CSF (5.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM-CSF (5.5 micrograms/kg protein dosage per day from day-6 to day-4 before chemotherapy)
Trial: 8221563
Drug: Chemotherapy only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy only (without GM-CSF)
Trial: 3304564
Drug: Methohexital (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methohexital (0.1 mg/kg/min continuous infusion)
Trial: 3304564
Drug: Thiopental (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental (5 mg/kg I.V. bolus)
Trial: 20118151
Drug: Bivalirudin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalirudin monotherapy with VCD
Trial: 18298700
Drug: Topiramate (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (all doses combined)
Trial: 10824049
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 2.5 mg amlodipine and 5 mg lisinopril
Trial: 10824049
Drug: Amlodipine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (2.5 mg and 5 mg) and Lisinopril (5 mg and 10 mg)
Trial: 1378112
Drug: Nifedipine SR
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine SR (50-100 mg once daily)
Trial: 1378112
Drug: Conventional nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional nifedipine tablet (20-40 mg twice daily)
Trial: 1378112
Drug: Conventional nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional nifedipine tablet
Trial: 7041665
Drug: Albendazole 400
RxNorm normalized name: albendazole 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole 400 mg single dose in adults
Trial: 7041665
Drug: Albendazole 400
RxNorm normalized name: albendazole 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole 400 mg per day for 3 consecutive days
Trial: 7041665
Drug: Albendazole 200
RxNorm normalized name: albendazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole 200 mg in children
Trial: 31788029
Drug: Autologous skin
RxNorm normalized name: Autologous skin culture
DrugBank: Autologous skin culture (DB18524)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous skin cell suspension (ReCell®)
Trial: 25132247
Drug: Dexmedetomidine (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (loading dose of 1 μg/kg followed by 0.2 μg/kg per h infusion)
Trial: 15871360
Drug: Topical administration
RxNorm normalized name: Octocaine 5 % Ointment for Oral and Topical Administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical administration of brimonidine tartrate
Trial: 11316161
Drug: 3 MU
RxNorm normalized name: Orasep Reformulated Dec 2013 Mucosal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 MU of interferon alpha‐2b and ribavirin (1000‐1200 mg/day) for 12 months
Trial: 11316161
Drug: 5 MU
RxNorm normalized name: MULTISTIX 5 MULTIPLE TEST STRIP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 MU of interferon alpha‐2b and ribavirin (1000‐1200 mg/day) for 12 months
Trial: 15374128
Drug: Controlled-release melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release melatonin (2 mg per night)
Trial: 8193492
Drug: Alfentanil 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 20 micrograms/kg plus suxamethonium 1.5 mg/kg
Trial: 9337490
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment for depression (CBT-D)
Trial: 11495176
Drug: Standard cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard cognitive-behavioral smoking cessation treatment (ST)
Trial: 20412090
Drug: 5% vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% vitamin K cream
Trial: 17272735
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg escitalopram for 12 weeks
Trial: 16210859
Drug: Desloratadine (DL)
RxNorm normalized name: Desloratadine
DrugBank: Desloratadine (DB00967)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desloratadine (DL) 20 mg daily for 4 weeks
Trial: 12014839
Drug: CoQ10 treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CoQ10 treatment in senescent rat hearts
Trial: 12014839
Drug: Oral CoQ10
RxNorm normalized name: CoQ10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral CoQ10 therapy for 2 weeks pre-operatively
Trial: 30166260
Drug: Tai Chi
RxNorm normalized name: Ma Chi Xian
DrugBank: Purslane (DB14327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tai Chi exercise program (3 times weekly for 3 months)
Trial: 28235533
Drug: Ropivacaine 0.1%
RxNorm normalized name: ROPivacaine 0.1% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.1% with fentanyl 2.5 μg/mL
Trial: 28235533
Drug: Bupivacaine 0.0625%
RxNorm normalized name: BUPIVACAINE 0.0625%/NS INJ 250ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.0625% with fentanyl 2.5 μg/mL
Trial: 28128983
Drug: EPA-enriched liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA-enriched liquid supplement (2 g/day)
Trial: 28128983
Drug: Powdered supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powdered supplement without EPA
Trial: 16787192
Drug: Prostaglandin E‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostaglandin E‐1 (PGE‐1) treatment
Trial: 15043177
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of a standard sliding-scale insulin regimen and routine diabetes medications
Trial: 15043177
Drug: Routine diabetes
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine diabetes medications (control)
Trial: 9279425
Drug: Treatment involving
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment involving observation over a nine-week period, with three weeks of treatment focused on lexical development and verb constructions.
Trial: 29948858
Drug: Adaptive servo-ventilation
RxNorm normalized name: Servo Stat Bac
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adaptive servo-ventilation (ASV) on top of standard therapy for acute heart failure
Trial: 23696211
Drug: Ultrasound-guided needling
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided needling and lavage (barbotage) combined with a US-guided corticosteroid injection in the subacromial bursa (group 1)
Trial: 23696211
Drug: Subacromial corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subacromial corticosteroid injection (SAI) alone (group 2)
Trial: 17469198
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (r-hGH), 1 mg every second day for 6 months followed by alternating daily injections of 1 mg and 0.5 mg for another 6 months
Trial: 19195665
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (r-hGH)
Trial: 8965780
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate added to the drug regimen
Trial: 1738927
Drug: Antibody-treated patients
RxNorm normalized name: trimethylsilyl treated diimethiconol-trimethylsiloxysilicate crosspolymer (45-55 WW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibody-treated patients
Trial: 1738927
Drug: Patients not
RxNorm normalized name: Lamictal 25mg-100mg Tablet Starter Kit (For Patients Not Taking Enzyme-Inducing Drugs or Valproate)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients not receiving antibody prophylaxis
Trial: 6423328
Drug: mannitol 0.5
RxNorm normalized name: MANNITOL 0.54%/SORBITOL 2.7% IRRG SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mannitol 0.5 g/kg body weight
Trial: 27913032
Drug: Fluticasone aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone aerosol combined with theophylline tablets
Trial: 27913032
Drug: Salmeterol/fluticasone aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone aerosol combined with placebo tablets
Trial: 20064514
Drug: Once-daily dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily dosing of delayed-release mesalamine (1.6-2.4 g/day)
Trial: 20064514
Drug: Twice-daily dosing
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily dosing of delayed-release mesalamine (1.6-2.4 g/day)
Trial: 8725181
Drug: Raloxifene HCl
RxNorm normalized name: raloxifene HCl
DrugBank: Raloxifene (DB00481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Raloxifene HCl 200 mg/day
Trial: 8725181
Drug: Raloxifene HCl
RxNorm normalized name: raloxifene HCl
DrugBank: Raloxifene (DB00481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Raloxifene HCl 600 mg/day
Trial: 8725181
Drug: Conjugated estrogens
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens (Premarin, 0.625 mg/day)
Trial: 26663669
Drug: Nightly 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nightly 50 mg sildenafil citrate
Trial: 24642191
Drug: Oral oxycodone
RxNorm normalized name: oxycodone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oxycodone 5mg plus acetaminophen 325mg
Trial: 18164965
Drug: GG genotype
RxNorm normalized name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection [Dengvaxia]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GG genotype of VEGF-1154 (A/G)
Trial: 9046850
Drug: 0.5% lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.5% lidocaine at 10 ml/hr
Trial: 9046850
Drug: 1% lidocaine
RxNorm normalized name: Icy Hot Max 4%-1% Lidocaine Pain Relief Dry Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% lidocaine at 10 ml/hr
Trial: 2058816
Drug: Bricanyl Turbuhaler
RxNorm normalized name: terbutaline sulfate Oral Solution [Bricanyl]
DrugBank: Terbutaline (DB00871)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bricanyl Turbuhaler (0.5 mg terbutaline sulphate)
Trial: 2058816
Drug: Ventolin Rotahaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ventolin Rotahaler (0.4 mg salbutamol)
Trial: 6575836
Drug: Cranial irradiation
RxNorm normalized name: geranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranial irradiation plus 5 doses of intrathecal methotrexate (i.t. MTX)
Trial: 25785701
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen (HBO) treatment breathing 100% oxygen under 2.5 ATA for 60 minutes
Trial: 24351352
Drug: Intravenous dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous dexamethasone preoperatively
Trial: 21368716
Drug: GTS-21 (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GTS-21 (150 mg, orally three times per day for 3 days)
Trial: 19636035
Drug: Drugs flagged
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drugs flagged as potentially inappropriate by Beers criteria
Trial: 19636035
Drug: Drugs flagged
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drugs flagged as potentially inappropriate by Zhan criteria
Trial: 19636035
Drug: Drugs identified
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drugs identified as problematic by the physician-pharmacist team
Trial: 19636035
Drug: Concordance between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concordance between drugs-to-avoid criteria and expert assessments
Trial: 15113949
Drug: Tomato juice
RxNorm normalized name: TOMATO JUICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tomato juice (330 mL/d for 2 weeks)
Trial: 15113949
Drug: Carrot juice
RxNorm normalized name: carrot juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carrot juice (330 mL/d for 2 weeks)
Trial: 31401165
Drug: Enalapril (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (5-10 mg/day)
Trial: 8089635
Drug: Control (alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (alpha methyldopa 500 mg/day)
Trial: 3316575
Drug: Cyclosporine alone
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine alone (15 to 17 mg/kg)
Trial: 3316575
Drug: Cyclosporine plus
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine plus prednisolone (0.3 mg/kg/d)
Trial: 3316575
Drug: Cyclosporine alone
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine alone (8 to 10 mg/kg/d)
Trial: 31858338
Drug: Oral treprostinil
RxNorm normalized name: Treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral treprostinil diolamine
Trial: 25967607
Drug: Hedan Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hedan Tablet 4.38 g/day
Trial: 23329206
Drug: Sumatriptan infusion
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sumatriptan infusion
Trial: 17189470
Drug: 2% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% chlorhexidine treatment after acid-etching
Trial: 15041116
Drug: Tadalafil with
RxNorm normalized name: Tadalafil
DrugBank: Tadalafil (DB00820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tadalafil with tadalafil dosing instructions
Trial: 11468015
Drug: diclofenac-K 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac-K 12.5 mg
Trial: 11468015
Drug: ibuprofen 200
RxNorm normalized name: ibuprofen 200 MG
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: ibuprofen 200 mg
Trial: 11468015
Drug: aspirin 500
RxNorm normalized name: aspirin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aspirin 500 mg
Trial: 2365538
Drug: SR nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR nicardipine (40 mg twice a day)
Trial: 2698934
Drug: Chlorthalidone (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone (25 mg once a day)
Trial: 227072
Drug: Tiapride (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiapride (300 mg/day, IM route)
Trial: 23979365
Drug: IV ART-123
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV ART-123 (0.06 mg/kg/d) for 6 days